Integrated Micro-Chromatography Systems

Integrated Micro-Chromatography Systems (IMCS) is a biotechnology company founded in 2012 and based in Columbia, South Carolina. The company's core mission is to deliver advanced tools and services to enhance scientific research and clinical diagnostics. IMCS offers a range of products including IMCSzyme, IMCSzyme RT, IMCStips, various proteins, enzymes, and resins, as well as specialized reagents like β-glucuronidase variants and Sulfazyme™. Their market focus spans across the biotechnology and pharmaceutical industries, providing essential components for research and development.

IMCS has garnered attention for its innovative contributions to the biotech field, with notable affiliations including partnerships with leading research institutions and healthcare providers. The company has secured investments from key industry players, which have bolstered its growth and development. Among its achievements, IMCS has been recognized for its high-quality products that streamline laboratory processes and improve diagnostic accuracy. Overall, IMCS has made a significant impact by advancing the capabilities of scientific research and clinical applications through its specialized biotechnological solutions.